Financial News
Novartis Ag ADR (NY: NVS )
108.19
+2.06
(+1.94%)
Streaming Delayed Price
Updated: 11:40 AM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about Novartis Ag ADR
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Big Players' Recent Trades in NVS Options
January 04, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/02/medical-tools-tech-therapeutics.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/02/vygr.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/01/Stock-HealthCareGurney-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/28/cing.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About Novartis?
November 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/26/bmy.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/758794/biotech-pharma-researchers-talk-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/21/calt.png?width=1200&height=800&fit=crop)
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/12/20/fusn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/19/lnth_logo.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/hot-stocks-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/15/mrk.png?width=1200&height=800&fit=crop)
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/12/11/nvs_co.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/757221/scientist-peers-into-microscope-in-laboratory.jpg)
![](https://www.investors.com/wp-content/uploads/2019/10/stock-Zoetis-04-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/06/nvs.png?width=1200&height=800&fit=crop)
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/11/29/fda-social-graphic.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600c.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/28/aapharma_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/11/TECHpic-seanbohen-112723-company.jpg)
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://g.foolcdn.com/editorial/images/754707/scientist-in-lab-young-african-american-female.jpg)
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-vervetherapeutics-02-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/753508/happy-older-couple-retirement-wealth-invest.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.